188Re-PTI-6D2

· Pain Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 188Re-PTI-6D2, covering 2011-07-14 to 2011-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma [Phase 1]